Eric conducted his graduate studies under the direction of Prof. Steven D. Townsend at Vanderbilt University. At Vanderbilt, he completed the total synthesis of the natural product Arimetamycin A and related derivatives. After obtaining his Ph.D. in 2021, he continued his training as a postdoctoral associate under the direction of Prof. Seth B. Herzon at Yale University. At Yale, he studied the mechanism of action of KL-50, a novel DNA crosslinker that selectively targets drug-resistant brain cancers. Following the completion of his postdoctoral training, he joined the chemistry faculty at Marquette University in August of 2023 as an Assistant Professor.